Intuitive Surgical's Da Vinci: Market Dominance and Future Competition

A report on Intuitive Surgical's Da Vinci surgical robot Q3 2024 financial results and a competitive analysis of the market, showing Da Vinci's high market share (approximately 80%) and high profitability (Recurring Revenue 83%), as well as an analysis of Intuitive Surgical's competitors, including Stryker, Johnson & Johnson, and Medtronic. The report also analyzes the trends of competitors such as Stryker, Johnson & Johnson, and Medtronic, especially their low-cost strategies and expansion into emerging markets, which could threaten Intuitive Surgical's future dominance of the market. While Da Vinci's dominance is expected to be maintained in the short term, concerns about increased competition in the long term are also expressed.